A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis

Affiliations

• ¹ Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing 100730, China.
• ² Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong 510006, China.
• ³ Department of Neurology, Chinese PLA General Hospital, Beijing 100853, China.
• ⁴ Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
• ⁵ Department of Neurology, Peking University Third Hospital, Beijing 100191, China.
• ⁶ Department of Health Statistics, Faculty of Health Service, Naval Medical University, Shanghai 200433, China.